$PMDI
PSYCHEMEDICS CORP Stock $pmdi

$pmdi Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000117184324001671 Filed on March 28, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$5.357M	$4.998M	$22.10M
YoY Change	-8.57%	-12.36%	-12.45%
Cost Of Revenue	$3.235M	$2.940M	$13.69M
YoY Change	-11.47%	-14.98%	-14.2%
Gross Profit	$2.122M	$2.058M	$8.413M
YoY Change	-3.76%	-8.33%	-9.45%
Gross Profit Margin	39.61%	41.18%	38.07%
Selling, General & Admin	$2.480M	$2.641M	$10.19M
YoY Change	1.85%	15.94%	12.62%
% of Gross Profit	116.87%	128.33%	121.12%
Research & Development	$209.0K	$285.0K	$1.144M
YoY Change	-29.87%	-11.76%	-13.73%
% of Gross Profit	9.85%	13.85%	13.6%
Depreciation & Amortization	$321.0K	$341.0K	$1.731M
YoY Change	-32.99%	-35.78%	-26.87%
% of Gross Profit	15.13%	16.57%	20.58%
Operating Expenses	$2.689M	$2.926M	$11.33M
YoY Change	-1.61%	12.5%	9.25%
Operating Profit	-$567.0K	-$868.0K	-$2.921M
YoY Change	7.39%	143.82%	169.71%
Interest Expense	-$4.000K	-$3.000K	-$17.00K
YoY Change	-20.0%	-50.0%	-139.53%
% of Operating Profit
Other Income/Expense, Net	-$5.000K	$2.000K	$7.000K
YoY Change	0.0%		-83.72%
Pretax Income	-$572.0K	-$876.0K	-$3.438M
YoY Change	7.32%	141.99%	230.58%
Income Tax	$116.0K	$69.00K	$716.0K
% Of Pretax Income
Net Earnings	-$688.0K	-$945.0K	-$4.154M
YoY Change	79.17%	37.35%	283.21%
Net Earnings / Revenue	-12.84%	-18.91%	-18.8%
Basic Earnings Per Share	-$0.12		-$0.72
Diluted Earnings Per Share	-$0.12	-$0.16	-$0.72
COMMON SHARES
Basic Shares Outstanding	5.806M	5.802M	5.740M
Diluted Shares Outstanding			5.740M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.421M	$1.964M	$1.964M
YoY Change	-67.56%	-58.65%	-58.65%
Cash & Equivalents	$1.421M	$1.964M	$1.964M
Short-Term Investments
Other Short-Term Assets	$870.0K	$1.136M	$1.136M
YoY Change	-20.04%	0.0%	0.0%
Inventory
Prepaid Expenses
Receivables	$3.883M	$3.687M	$3.687M
Other Receivables	$13.00K	$18.00K	$18.00K
Total Short-Term Assets	$6.187M	$6.805M	$6.805M
YoY Change	-35.11%	-31.7%	-31.7%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.357M	$4.889M	$4.889M
YoY Change	-34.79%	-32.6%	-32.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$608.0K	$632.0K	$132.0K
YoY Change	-27.62%	-58.26%	-91.28%
Total Long-Term Assets	$4.965M	$5.521M	$5.521M
YoY Change	-40.7%	-37.03%	-37.03%
TOTAL ASSETS
Total Short-Term Assets	$6.187M	$6.805M	$6.805M
Total Long-Term Assets	$4.965M	$5.521M	$5.521M
Total Assets	$11.15M	$12.33M	$12.33M
YoY Change	-37.72%	-34.2%	-34.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.131M	$752.0K	$752.0K
YoY Change	44.08%	67.86%	67.86%
Accrued Expenses	$1.780M	$3.652M	$3.652M
YoY Change	-50.99%	-26.61%	-26.61%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$230.0K	$305.0K	$305.0K
YoY Change	-22.56%	3.74%	3.74%
Total Short-Term Liabilities	$4.184M	$4.709M	$4.709M
YoY Change	-27.74%	-17.65%	-17.65%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Other Long-Term Liabilities	$687.0K	$945.0K	$945.0K
YoY Change	-60.08%	-51.24%	-51.24%
Total Long-Term Liabilities	$687.0K	$945.0K	$945.0K
YoY Change	198.7%	-57.87%	-57.87%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.184M	$4.709M	$4.709M
Total Long-Term Liabilities	$687.0K	$945.0K	$945.0K
Total Liabilities	$4.871M	$5.654M	$5.654M
YoY Change	-37.08%	-28.98%	-28.98%
SHAREHOLDERS EQUITY
Retained Earnings	-$17.46M	-$16.77M
YoY Change	38.56%	41.9%
Common Stock	$35.46M	$35.16M
YoY Change	2.82%	2.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$10.08M	$10.08M
YoY Change		0.0%
Treasury Stock Shares
Shareholders Equity	$6.281M	$6.672M	$6.672M
YoY Change
Total Liabilities & Shareholders Equity	$11.15M	$12.33M	$12.33M
YoY Change	-37.72%	-34.2%	-34.2%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$688.0K	-$945.0K	-$4.154M
YoY Change	79.17%	37.35%	283.21%
Depreciation, Depletion And Amortization	$321.0K	$341.0K	$1.731M
YoY Change	-32.99%	-35.78%	-26.87%
Cash From Operating Activities	-$473.0K	$660.0K	-$1.480M
YoY Change	110.22%	-65.15%	-130.27%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$27.00K	$157.0K
YoY Change	-100.0%	12.5%	-16.04%
Acquisitions
YoY Change
Other Investing Activities	$13.00K	$28.00K	-$2.000K
YoY Change	-140.63%	600.0%	-90.48%
Cash From Investing Activities	$5.000K	$1.000K	-$159.0K
YoY Change	-106.85%	-105.0%	-23.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$54.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$75.00K	-77.00K	-1.147M
YoY Change	4.17%	-86.77%	-40.38%
NET CHANGE
Cash From Operating Activities	-$473.0K	660.0K	-1.480M
Cash From Investing Activities	$5.000K	1.000K	-159.0K
Cash From Financing Activities	-$75.00K	-77.00K	-1.147M
Net Change In Cash	-$543.0K	584.0K	-2.786M
YoY Change	46.76%	-54.8%	-201.02%
FREE CASH FLOW
Cash From Operating Activities	-$473.0K	$660.0K	-$1.480M
Capital Expenditures	$0.00	$27.00K	$157.0K
Free Cash Flow	-$473.0K	$633.0K	-$1.637M
YoY Change	93.06%	-66.15%	-134.81%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000806517
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2022	us-gaap	Interest Income Other InterestIncomeOther	0	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	0	usd
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y10M24D
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y1M6D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M6D
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.505	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.462	pure
CY2022	pmd	Income Tax Reconciliation Foreign Income Tax Witholdings IncomeTaxReconciliationForeignIncomeTaxWitholdings	-0.109	pure
CY2023	pmd	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	-0.004	pure
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	22100000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5805611
CY2023	dei	Auditor Firm AuditorFirmId	243
CY2023	dei	Auditor Name AuditorName	BDO USA, P.C.
CY2023	dei	Auditor Location AuditorLocation	Boston, Massachusetts
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1964000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4750000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	64000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	87000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3687000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3739000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1136000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1136000	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	18000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	339000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	6805000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	9964000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	4774000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	4648000	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2253000	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2247000	usd
CY2023Q4	pmd	Laboratory Equipment LaboratoryEquipment	16038000	usd
CY2022Q4	pmd	Laboratory Equipment LaboratoryEquipment	16013000	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3629000	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3629000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	26694000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	26537000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23633000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21964000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3061000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4573000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	632000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	823000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	691000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1828000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2681000	usd
CY2023Q4	us-gaap	Assets Assets	12326000	usd
CY2022Q4	us-gaap	Assets Assets	18732000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	752000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	448000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2604000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3939000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	305000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	294000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1048000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1037000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4709000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5718000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	305000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	945000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1938000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	5654000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	7961000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.005
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.005
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	873000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	873000
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6474000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6349000
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5806000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5681000
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	32000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	32000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	35129000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	34275000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	668000
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	668000
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10082000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10082000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16773000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11820000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1634000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1634000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6672000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	10771000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12326000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18732000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	22098000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	25240000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	13685000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	15949000	usd
CY2023	us-gaap	Gross Profit GrossProfit	8413000	usd
CY2022	us-gaap	Gross Profit GrossProfit	9291000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7192000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5857000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2998000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3191000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1144000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1326000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	11334000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	10374000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-2921000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1083000	usd
CY2022	pmd	Other Nonoperating Expense Settlement OtherNonoperatingExpenseSettlement	-0	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-517000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1040000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4154000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.72
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5740000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5626000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5740000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5626000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12243000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	0
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	4000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	872000	usd
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.21
CY2022	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1186000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1084000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	10771000	usd
CY2023	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	54000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	908000	usd
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.14
CY2023	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	799000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4154000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6672000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4154000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1084000	usd
CY2023	pmd	Depreciation And Amortization Excluding Rou Asset Amortization DepreciationAndAmortizationExcludingRouAssetAmortization	1731000	usd
CY2022	pmd	Depreciation And Amortization Excluding Rou Asset Amortization DepreciationAndAmortizationExcludingRouAssetAmortization	2367000	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	939000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	949000	usd
CY2023	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-691000	usd
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	531000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	908000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	872000	usd
CY2023	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-131000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-52000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-377000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-0	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-363000	usd
CY2023	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-321000	usd
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-2339000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	304000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-546000	usd
CY2023	pmd	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-1068000	usd
CY2022	pmd	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-967000	usd
CY2023	pmd	Increase Decrease In Accrued Expenses And Accrued Income Taxes IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes	-1335000	usd
CY2022	pmd	Increase Decrease In Accrued Expenses And Accrued Income Taxes IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes	751000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1480000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4890000	usd
CY2023	pmd	Payments For Proceeds From Other Assets PaymentsForProceedsFromOtherAssets	2000	usd
CY2022	pmd	Payments For Proceeds From Other Assets PaymentsForProceedsFromOtherAssets	21000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	157000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	187000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-159000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-208000	usd
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	799000	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1186000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-54000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-74000	usd
CY2023	pmd	Payments Of Equipment Financing PaymentsOfEquipmentFinancing	294000	usd
CY2022	pmd	Payments Of Equipment Financing PaymentsOfEquipmentFinancing	664000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1147000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1924000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2786000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2758000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4750000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1992000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1964000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4750000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	18000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	33000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	1167000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1044000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	86000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	78000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2000000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><i>Estimates</i></b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt; text-align: justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates, including those related to bad debts, long-lived asset lives, income tax valuation and share based compensation, and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Changes in estimates are recorded in the period in which they become known.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p>
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1700000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2400000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5740000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	208000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	208000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	208000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	208000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	208000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	61000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	22098000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	25240000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5626000
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><i>Concentration of Credit Risk and Off-Balance Sheet Risk</i></b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt; text-align: justify;">Financial instruments that potentially subject us to concentrations of credit risk are principally cash and accounts receivable. Our policy is to place our cash in high quality financial institutions. At times, including presently, these deposits may exceed or be exempt from federally insured limits. We do not believe significant credit risk exists with respect to these institutions. Concentration of credit risk with respect to accounts receivable is limited to certain customers to whom we make substantial sales. To reduce risk, we routinely assess the financial strength of our customers and, as a consequence, believe that our accounts receivable credit risk exposure is limited. We maintain an allowance for potential credit losses but historically have not experienced any significant losses related to individual customers or groups of customers in any particular industry or geographic area. We do not require collateral. We have no significant off-balance-sheet risk such as foreign exchange contracts, option contracts, or other foreign hedging arrangements.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p>
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	908000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	872000	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5740000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5626000
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	652000
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	746000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	87000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	89000	usd
CY2023	pmd	Provision For Recoveries Of Doubtful Accounts ProvisionForRecoveriesOfDoubtfulAccounts	-15000	usd
CY2022	pmd	Provision For Recoveries Of Doubtful Accounts ProvisionForRecoveriesOfDoubtfulAccounts	9000	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	8000	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	11000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	64000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	87000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	640000	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	442000	usd
CY2023Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	317000	usd
CY2022Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	409000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	553000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	771000	usd
CY2023Q4	pmd	Accrued Shipping Current AccruedShippingCurrent	113000	usd
CY2022Q4	pmd	Accrued Shipping Current AccruedShippingCurrent	338000	usd
CY2023Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	167000	usd
CY2022Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	1150000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	814000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	829000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2604000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3939000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	99000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	552000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-75000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	23000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	24000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	575000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	146000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-959000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	546000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	428000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	692000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-531000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	716000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	44000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.021	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.12	pure
CY2022	pmd	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	-0.004	pure
CY2023	pmd	Effective Income Tax Rate Reconciliation Nondeductible Expense Benefit Sharebased Compensation Cost Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseBenefitSharebasedCompensationCostPercent	-0.012	pure
CY2022	pmd	Effective Income Tax Rate Reconciliation Nondeductible Expense Benefit Sharebased Compensation Cost Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseBenefitSharebasedCompensationCostPercent	0.005	pure
CY2023	pmd	Effective Income Tax Rate Reconciliation Tax Credit Expense Research Percent EffectiveIncomeTaxRateReconciliationTaxCreditExpenseResearchPercent	0.035	pure
CY2022	pmd	Effective Income Tax Rate Reconciliation Tax Credit Expense Research Percent EffectiveIncomeTaxRateReconciliationTaxCreditExpenseResearchPercent	0.089	pure
CY2023	pmd	Income Tax Reconciliation Foreign Income Tax Witholdings IncomeTaxReconciliationForeignIncomeTaxWitholdings	0	pure
CY2023	pmd	Effective Income Tax Rate Reconciliation Change In Tax Rate For Carryback Claim EffectiveIncomeTaxRateReconciliationChangeInTaxRateForCarrybackClaim	0	pure
CY2022	pmd	Effective Income Tax Rate Reconciliation Change In Tax Rate For Carryback Claim EffectiveIncomeTaxRateReconciliationChangeInTaxRateForCarrybackClaim	0	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.208	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.042	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3500000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	900000	usd
CY2023Q4	pmd	Deferred Tax Assets Liabilities Net1 DeferredTaxAssetsLiabilitiesNet1	2600000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2600000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	15000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	21000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	154000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	414000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	358000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	381000	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1193000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1086000	usd
CY2023Q4	pmd	Deferred Tax Assets Operating Lease DeferredTaxAssetsOperatingLease	488000	usd
CY2022Q4	pmd	Deferred Tax Assets Operating Lease DeferredTaxAssetsOperatingLease	701000	usd
CY2023Q4	pmd	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	1228000	usd
CY2022Q4	pmd	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	404000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	87000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	72000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3523000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3079000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2579000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	895000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	944000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2184000	usd
CY2023Q4	pmd	Deferred Tax Liabilities Excess Of Tax Over Book Depreciation And Amortization DeferredTaxLiabilitiesExcessOfTaxOverBookDepreciationAndAmortization	447000	usd
CY2022Q4	pmd	Deferred Tax Liabilities Excess Of Tax Over Book Depreciation And Amortization DeferredTaxLiabilitiesExcessOfTaxOverBookDepreciationAndAmortization	783000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	70000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	78000	usd
CY2023Q4	pmd	Deferred Tax Liabilities Operating Lease DeferredTaxLiabilitiesOperatingLease	427000	usd
CY2022Q4	pmd	Deferred Tax Liabilities Operating Lease DeferredTaxLiabilitiesOperatingLease	632000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	944000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1493000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	691000	usd
CY2020Q4	us-gaap	Share Price SharePrice	1.93
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	508000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.19
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	25000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	420000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.36
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	12000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.13
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	404000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	14.26
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	512000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.32
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	90000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	15.53
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023Q4	us-gaap	Share Price SharePrice	2.96
CY2022Q4	us-gaap	Share Price SharePrice	4.9
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	786	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	548000	usd
CY2023	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	670000	usd
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	650000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1200000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y5M19D
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	1100000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	1000000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.039	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y1M6D
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	1100000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	1000000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1061000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	553000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	460000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2074000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	81000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1993000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1048000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	945000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1993000	usd
CY2023	us-gaap	Interest Expense InterestExpense	17000	usd
CY2022	us-gaap	Interest Expense InterestExpense	32000	usd
CY2023	pmd	Settlement Expense SettlementExpense	507000	usd
CY2022	pmd	Settlement Expense SettlementExpense	0	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	22098000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	25240000	usd

Files In Submission

Name	View Source	Status
0001171843-24-001671-index-headers.html	Edgar Link	pending
0001171843-24-001671-index.html	Edgar Link	pending
0001171843-24-001671.txt	Edgar Link	pending
0001171843-24-001671-xbrl.zip	Edgar Link	pending
ex_641973.htm	Edgar Link	pending
ex_641974.htm	Edgar Link	pending
ex_641975.htm	Edgar Link	pending
ex_641976.htm	Edgar Link	pending
ex_641977.htm	Edgar Link	pending
ex_641978.htm	Edgar Link	pending
ex_641979.htm	Edgar Link	pending
ex_641980.htm	Edgar Link	pending
ex_646588.htm	Edgar Link	pending
ex_646589.htm	Edgar Link	pending
ex_646590.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
logo.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pmd-20231231.xsd	Edgar Link	pending
pmd20231231_10k.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
pmd-20231231_cal.xml	Edgar Link	unprocessable
pmd-20231231_def.xml	Edgar Link	unprocessable
pmd-20231231_lab.xml	Edgar Link	unprocessable
pmd-20231231_pre.xml	Edgar Link	unprocessable
pmd20231231_10k_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PMDI
PSYCHEMEDICS CORP Stock $pmdi

2024 Q1 Form 10-K Financial Statement

#000117184324001671 Filed on March 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMDI PSYCHEMEDICS CORP Stock $pmdi

2024 Q1 Form 10-K Financial Statement

#000117184324001671 Filed on March 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMDI
PSYCHEMEDICS CORP Stock $pmdi